seed
Stage
About
metaLinear is a biotechnology company focused on identifying and validating new drug targets for difficult-to-treat bacterial infections. It uses protein-engineering-based technology to accelerate discovery and development of new classes of antibiotics.
Explore metaLinear's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.